Role of Tyrosine in MDMA Toxicity
Role of Tyrosine in MDMA Toxicity
批准号:
7367125
负责人:
Bryan K Yamamoto
金额:
$18.26万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-10 至 2008-07-15
关键词:
AddressAffectAmino AcidsAmphetamine AbuseAromatic-L-Amino-Acid DecarboxylasesBrainCarboxy-LyasesCell SurvivalCellsDataDependencyDetectionDopamineDyesEnvironmentFeverFluorescamineHippocampus (Brain)Hydrogen PeroxideIncubatedIndividualInduced HyperthermiaLactate DehydrogenaseLactate DehydrogenasesLipid PeroxidationMeasuresMediatingMediator of activation proteinMembrane PotentialsMicrodialysisMitochondriaModelingNerve DegenerationNeuronsNeutral Amino AcidsOxidative StressPresynaptic TerminalsProcessProxyQuinonesReactive Oxygen SpeciesRelative (related person)Research PersonnelRoleSerotoninSystemTemperatureTestingToxic effectTyramineTyrosineanalogbasebenzoquinonedopaminergic neuronecstasyextracellularhyperthermia treatmentin vivomitochondrial membraneneurotoxicitynovelnovel strategiesoxidationresearch study
中文摘要
广泛滥用的安非他明类似物,3,4-亚甲二氧基甲基安非他明(摇头丸,摇头丸)
选择性损伤脑内5-HT神经元的轴突末梢。有证据表明多巴胺
(DA)导致了这种毒性。虽然DA明显产生氧化副产物,如活性氧
和醌类化合物,目前尚不清楚DA衍生的氧化物质如何对5 HT末端产生选择性损伤,
MDMA诱导的神经毒性的标志。更具体地说,DA在5-HT内蓄积的机制
终端产生其选择性损害是未知的。当前提案的过度假设是L-
酪氨酸是DA的氨基酸前体,有助于神经变性过程。这个假设是基于
我们最近的初步数据表明,在体内测量的细胞外酪氨酸浓度增加了5倍,
在摇头丸之后与DA不同,酪氨酸从外周积极转运到大脑和神经元中。而
酪氨酸是DA神经元内DA合成的天然前体,在5 HT神经元中高浓度的酪氨酸
可能会产生有害后果。这一建议的假设框架是,
MDMA和5-HT神经元中的高温产生的多巴胺引起酪氨酸非酶促氧化为DA
前体多巴芳香族氨基酸脱羧酶(AADC),位于5-HT末端,
DOPA转化为DA,导致DA积累,从而导致DA衍生的活性氧和氧化
5 HT端子内损坏。酪氨酸作为MDMA诱导的毒性的介导剂的这种假设作用是一种新的机制。
有效综合目前现有假设的机制,在某种程度上,不一致的意见,
将明显的警告纳入一个有凝聚力的、理论的和可测试的框架。
具体目的是:(1)证明酪氨酸在5 HT内非酶促氧化为多巴和多巴胺
(2)研究L-酪氨酸和酪胺对MDMA和高血压诱导的氧化损伤的作用。
应激和(3)评估随后的神经元损伤。使用培养的RN 46 A 5 HT细胞是一种新的方法,
是唯一适合于解决MDMA诱导损伤的假设机制。这些实验将直接
测量摇头丸、酪氨酸、高温和细胞内形成的个体和相对影响
多巴胺对5-HT神经元内氧化过程的影响以及这些变量如何影响细胞活力。测试这个
模型结合体内微透析研究,提供了一种独特而强大的方法来解决神秘的
先前与MDMA诱导的5 HT系统神经变性相关的问题。
英文摘要
The widely abused amphetamine analogue, 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)
selectively damages the axon terminals of 5-HT neurons in the brain. Several lines of evidence suggest that dopamine
(DA) contributes to this toxicity. Although DA clearly produces oxidative by-products such as reactive oxygen species
and quinones, it remains unclear as to how DA-derived oxidative species produce selective damage to 5HT terminals, a
hallmark of MDMA-induced neurotoxicity. More specifically, the mechanism as to how DA accumulates within 5-HT
terminals to produce its selective damage is unknown. The overaraching hypothesis of the current proposal is that L-
tyrosine, the amino acid precursor of DA, contributes to the neurodegenerative process. This hypothesis is based on
our recent preliminary data indicating a 5-fold increase in the extracellular concentration of tyrosine measured in vivo
after MDMA. Unlike DA, tyrosine is actively transported from the periphery and into the brain and neurons. While
tyrosine is the natural precursor for DA synthesis within DA neurons, high concentrations of tyrosine in 5HT neurons
may have deleterious consequences. The hypothetical framework of this proposal is that the oxidative environment
produced by MDMA and hyperthermia in 5-HT neurons causes the non-enzymatic oxidation of tyrosine to the DA
precursor, DOPA. Aromatic amino acid decarboxylase (AADC), within the 5-HT terminal then would decarboxylate
DOPA to DA, leading to an accumulation of DA and consequently, DA-derived reactive oxygen species and oxidative
damage within 5HT terminals. This hypothesized role of tyrosine as a mediator of MDMA-induced toxicity is a novel
mechanism that effectively synthesizes current existing hypotheses and to some extent, discrepant observations and
apparent caveats into a cohesive, theoretical and testable framework.
The Specific Aims are (1) to demonstrate the non-enzymatic oxidation of tyrosine to DOPA and DA within 5HT
neurons, (2) to characterize the contributions of L-tyrosine and tyramine to MDMA and hyperthermia-induced oxidative
stress and (3) to assess subsequent neuronal damage. The use of cultured RN46A 5HT cells is a novel approach that
is uniquely suited to address the hypothesized mechanism of MDMA-induced damage. These experiments will directly
measure the individual and relative effects of MDMA, tyrosine, hyperthermia, and the formation of intracellular
dopamine on oxidative processes within 5-HT neurons and how these variables affect cell viability. The testing of this
model in conjunction with in vivo microdialysis studies, provides a unique and powerful approach to address enigmatic
issues previously related to MDMA-induced neurodegeneration of 5HT systems.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methamphetamine-Alcohol Interactions and Mechanisms of Augmented Toxicity to Brain and Peripheral Organs
-
批准号:9381361
-
项目类别:
-
资助金额:$50.68万
-
财政年份:2017
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:8599015
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:8661737
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:9122805
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine, Stress and Brain Endothelium
-
批准号:9044745
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2013
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7795247
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7196550
-
项目类别:
-
资助金额:$27.61万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7579929
-
项目类别:
-
资助金额:$24.7万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7664115
-
项目类别:
-
资助金额:$8.8万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Role of Tyrosine in MDMA Toxicity
-
批准号:7032142
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2006
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6872592
-
项目类别:
-
资助金额:$0.82万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6694381
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:7070101
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6921502
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
Chronic Stress and MDMA Neurotoxicity
-
批准号:6778353
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2003
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120086
-
项目类别:
-
资助金额:$13.07万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120088
-
项目类别:
-
资助金额:$20.1万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:2120087
-
项目类别:
-
资助金额:$21.4万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
Methamphetamine Toxicity and Corticostriatal Glutamate
-
批准号:7816726
-
项目类别:
-
资助金额:$47.22万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
METHAMPHETAMINE TOXICITY AND CORTICOSTRIATAL GLUTAMATE
-
批准号:6191387
-
项目类别:
-
资助金额:$32.69万
-
财政年份:1992
-
负责人:Bryan K Yamamoto
-
依托单位:
海外基金